Recombinant simian varicella virus-simian immunodeficiency virus vaccine induces t and b cell functions and provides partial protection against repeated mucosal siv challenges in rhesus macaques

HIGHLIGHTS

• who: Bapi Pahar and colleagues from the Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, USA School of Medicine, Tulane University, New Orleans, LA, USA have published the research work: Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques, in the Journal: Viruses 2022, 14, x FOR PEER REVIEW of /2022/
• what: This study shows that varicella virus-vectored SIV vaccination with protein boosts induces a 37.5% efficacy rate pathogenic SIV challenge by generating . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.